Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
Ribosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of protein synthesis and diseases called “ribosomopathies,” including genetic disorders with cancer risk. However, the potential role of rRNA gene...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2409 |
id |
doaj-bbb0d54a6cf148f4a62a2177a1c8183c |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Riuko Ohashi Hajime Umezu Ayako Sato Tatsuya Abé Shuhei Kondo Kenji Daigo Seijiro Sato Norikazu Hara Akinori Miyashita Takeshi Ikeuchi Teiichi Motoyama Masashi Kishi Tadahiro Nagaoka Keiko Horiuchi Atsushi Shiga Shujiro Okuda Tomoki Sekiya Aya Ohtsubo Kosuke Ichikawa Hiroshi Kagamu Toshiaki Kikuchi Satoshi Watanabe Jun-Ichi Tanuma Peter Schraml Takao Hamakubo Masanori Tsuchida Yoichi Ajioka |
spellingShingle |
Riuko Ohashi Hajime Umezu Ayako Sato Tatsuya Abé Shuhei Kondo Kenji Daigo Seijiro Sato Norikazu Hara Akinori Miyashita Takeshi Ikeuchi Teiichi Motoyama Masashi Kishi Tadahiro Nagaoka Keiko Horiuchi Atsushi Shiga Shujiro Okuda Tomoki Sekiya Aya Ohtsubo Kosuke Ichikawa Hiroshi Kagamu Toshiaki Kikuchi Satoshi Watanabe Jun-Ichi Tanuma Peter Schraml Takao Hamakubo Masanori Tsuchida Yoichi Ajioka Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients Cells lung adenocarcinoma rDNA ribosome biogenesis single nucleotide variant prognosis |
author_facet |
Riuko Ohashi Hajime Umezu Ayako Sato Tatsuya Abé Shuhei Kondo Kenji Daigo Seijiro Sato Norikazu Hara Akinori Miyashita Takeshi Ikeuchi Teiichi Motoyama Masashi Kishi Tadahiro Nagaoka Keiko Horiuchi Atsushi Shiga Shujiro Okuda Tomoki Sekiya Aya Ohtsubo Kosuke Ichikawa Hiroshi Kagamu Toshiaki Kikuchi Satoshi Watanabe Jun-Ichi Tanuma Peter Schraml Takao Hamakubo Masanori Tsuchida Yoichi Ajioka |
author_sort |
Riuko Ohashi |
title |
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients |
title_short |
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients |
title_full |
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients |
title_fullStr |
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients |
title_full_unstemmed |
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients |
title_sort |
frequent germline and somatic single nucleotide variants in the promoter region of the ribosomal rna gene in japanese lung adenocarcinoma patients |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2020-11-01 |
description |
Ribosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of protein synthesis and diseases called “ribosomopathies,” including genetic disorders with cancer risk. However, the potential role of rRNA gene (rDNA) alterations in cancer is unknown. We investigated germline and somatic single-nucleotide variants (SNVs) in the rDNA promoter region (positions −248 to +100, relative to the transcription start site) in 82 lung adenocarcinomas (LUAC). Twenty-nine tumors (35.4%) carried germline SNVs, and eight tumors (9.8%) harbored somatic SNVs. Interestingly, the presence of germline SNVs between positions +1 and +100 (<i>n</i> = 12; 14.6%) was associated with significantly shorter recurrence-free survival (RFS) and overall survival (OS) by univariate analysis (<i>p</i> < 0.05, respectively), and was an independent prognostic factor for RFS and OS by multivariate analysis. LUAC cell line PC9, carrying rDNA promoter SNV at position +49, showed significantly higher ribosome biogenesis than H1650 cells without SNV. Upon nucleolar stress induced by actinomycin D, PC9 retained significantly higher ribosome biogenesis than H1650. These results highlight the possible functional role of SNVs at specific sites of the rDNA promoter region in ribosome biogenesis, the progression of LUAC, and their potential prognostic value. |
topic |
lung adenocarcinoma rDNA ribosome biogenesis single nucleotide variant prognosis |
url |
https://www.mdpi.com/2073-4409/9/11/2409 |
work_keys_str_mv |
AT riukoohashi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT hajimeumezu frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT ayakosato frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT tatsuyaabe frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT shuheikondo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT kenjidaigo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT seijirosato frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT norikazuhara frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT akinorimiyashita frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT takeshiikeuchi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT teiichimotoyama frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT masashikishi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT tadahironagaoka frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT keikohoriuchi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT atsushishiga frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT shujirookuda frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT tomokisekiya frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT ayaohtsubo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT kosukeichikawa frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT hiroshikagamu frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT toshiakikikuchi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT satoshiwatanabe frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT junichitanuma frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT peterschraml frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT takaohamakubo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT masanoritsuchida frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients AT yoichiajioka frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients |
_version_ |
1724430311339589632 |
spelling |
doaj-bbb0d54a6cf148f4a62a2177a1c8183c2020-11-25T04:06:54ZengMDPI AGCells2073-44092020-11-0192409240910.3390/cells9112409Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma PatientsRiuko Ohashi0Hajime Umezu1Ayako Sato2Tatsuya Abé3Shuhei Kondo4Kenji Daigo5Seijiro Sato6Norikazu Hara7Akinori Miyashita8Takeshi Ikeuchi9Teiichi Motoyama10Masashi Kishi11Tadahiro Nagaoka12Keiko Horiuchi13Atsushi Shiga14Shujiro Okuda15Tomoki Sekiya16Aya Ohtsubo17Kosuke Ichikawa18Hiroshi Kagamu19Toshiaki Kikuchi20Satoshi Watanabe21Jun-Ichi Tanuma22Peter Schraml23Takao Hamakubo24Masanori Tsuchida25Yoichi Ajioka26Histopathology Core Facility, Niigata University Faculty of Medicine, Niigata 951-8510, JapanDivision of Pathology, Niigata University Medical & Dental Hospital, Niigata 951-8520, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa 211-8533, JapanDivision of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8510, JapanDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8510, JapanDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8510, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanNeuroscience Laboratory, Research Institute, Nozaki Tokushukai Hospital, Osaka 574-0074, JapanDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science, Fujita Health University, Aichi 470-1192, JapanDepartment of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa 211-8533, JapanDepartment of Clinical Laboratory, Niigata Cancer Center hospital, Niigata 951-8560, JapanDivision of Bioinformatics, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDivision of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8514, JapanDepartment of Pathology and Molecular Pathology, University of Zurich and University Hospital Zurich, CH-8091 Zurich, SwitzerlandDepartment of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa 211-8533, JapanDivision of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanHistopathology Core Facility, Niigata University Faculty of Medicine, Niigata 951-8510, JapanRibosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of protein synthesis and diseases called “ribosomopathies,” including genetic disorders with cancer risk. However, the potential role of rRNA gene (rDNA) alterations in cancer is unknown. We investigated germline and somatic single-nucleotide variants (SNVs) in the rDNA promoter region (positions −248 to +100, relative to the transcription start site) in 82 lung adenocarcinomas (LUAC). Twenty-nine tumors (35.4%) carried germline SNVs, and eight tumors (9.8%) harbored somatic SNVs. Interestingly, the presence of germline SNVs between positions +1 and +100 (<i>n</i> = 12; 14.6%) was associated with significantly shorter recurrence-free survival (RFS) and overall survival (OS) by univariate analysis (<i>p</i> < 0.05, respectively), and was an independent prognostic factor for RFS and OS by multivariate analysis. LUAC cell line PC9, carrying rDNA promoter SNV at position +49, showed significantly higher ribosome biogenesis than H1650 cells without SNV. Upon nucleolar stress induced by actinomycin D, PC9 retained significantly higher ribosome biogenesis than H1650. These results highlight the possible functional role of SNVs at specific sites of the rDNA promoter region in ribosome biogenesis, the progression of LUAC, and their potential prognostic value.https://www.mdpi.com/2073-4409/9/11/2409lung adenocarcinomarDNAribosome biogenesissingle nucleotide variantprognosis |